Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035312 | SCV000058960 | likely benign | not specified | 2012-09-21 | criteria provided, single submitter | clinical testing | 801+14C>T in intron 5 of GLA: This variant is not expected to have clinical sign ificance because it is not located within the splice consensus sequence. 801+14 C>T in intron 5 of GLA (allele frequency = n/a) |
Gene |
RCV000035312 | SCV000535906 | likely benign | not specified | 2017-01-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002054556 | SCV002455720 | likely benign | Fabry disease | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000035312 | SCV003934333 | uncertain significance | not specified | 2023-05-15 | criteria provided, single submitter | clinical testing |